文献速递慢阻肺

心力衰竭与慢阻肺急性加重风险的关系

Relationship between heart failure and the risk of acute exacerbation of COPD.
PubMed 文献 · Thorax · 2021-04-29

新诊断心力衰竭(aHR 1.45,95%CI 1.30-1.62)和可能心力衰竭(aHR 1.65,95%CI 1.58-1.72)均相似地增加中重度急性加重风险。所有心力衰竭药物的新发和现有使用均与加重风险增加相关,现有使用较新发使用风险降低。

要点

  • 新诊断和可能心力衰竭均增加慢阻肺中重度急性加重风险
  • 所有心力衰竭药物新发使用与加重风险增加相关
  • 现有使用较新发使用急性加重风险降低

核心结论

  • 慢阻肺患者中心力衰竭的诊断和管理存在被延误的机会,管理心力衰竭可能长期降低急性加重风险。

主要发现

  • 新诊断心力衰竭(aHR 1.45,95%CI 1.30-1.62)和可能心力衰竭(aHR 1.65,95%CI 1.58-1.72)相似地增加急性加重风险。
  • 所有心力衰竭药物的新发和现有使用均与急性加重风险增加相关。
  • 现有使用较新发使用与急性加重风险降低相关。

临床怎么用

  • 在慢阻肺患者中应早期识别和管理心力衰竭,可能有助于长期降低急性加重风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Heart failure (HF) management in chronic obstructive pulmonary disease (COPD) is often delayed or suboptimal. OBJECTIVES: To examine the effect of HF and HF medication use on moderate-to-severe COPD exacerbations. METHODS AND MEASUREMENTS: Retrospective cohort studies from 2006 to 2016 using nationally representative English primary care electronic healthcare records linked to national hospital and mortality data. Patients with COPD with diagnosed and possible HF were identified. Possible HF was defined as continuous loop diuretic use in the absence of a non-cardiac indication. Incident exposure to HF medications was defined as ≥2 prescriptions within 90 days with no gaps >90 days during ≤6 months of continuous use; prevalent exposure as 6+ months of continuous use. HF medications investigated were angiotensin receptor blockers, ACE inhibitors, beta-blockers, loop diuretics and mineralocorticoid receptor antagonists. Cox regression, stratified by sex and age, further adjusted for patient characteristics, was used to determine the association of HF with exacerbation risk. MAIN RESULTS: 86 795 patients with COPD were categorised as no evidence of HF (n=60 047), possible HF (n=8476) and newly diagnosed HF (n=2066). Newly diagnosed HF (adjusted HR (aHR): 1.45, 95% CI: 1.30 to 1.62) and possible HF (aHR: 1.65, 95% CI: 1.58 to 1.72) similarly increased exacerbation risk. Incident and prevalent use of all HF medications were associated with increased exacerbation risk. Prevalent use was associated with reduced exacerbation risk compared with incident use. CONCLUSIONS: Earlier opportunities to improve the diagnosis and management of HF in the COPD population are missed. Managing HF may reduce exacerbation risk in the long term.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Axson EL, Bottle A, Cowie MR, et al. Relationship between heart failure and the risk of acute exacerbation of COPD. Thorax. 2021. PMID: 33927022. doi:10.1136/thoraxjnl-2020-216390

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。